TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of a Virtual Coach in Improving Adherence to an Activity Program for Overweight Adults
Brief Summary: Hypothesis: Overweight subjects using a Virtual Coach will demonstrate improved adherence to an exercise regime.

This study is designed to examine the effect of a computer program called a "Virtual Coach" and find out if it helps people become more active. This program acts as a kind of a personal trainer and will give you feedback. All participants in the study will receive an activity monitor to wear during the study and a website to use to track activity. Half of the participants will also receive the virtual coach software. This software will have to be downloaded onto your computer, and we will ask that you check in with the coach using the software three times a week for 12 weeks. The group you will be placed in will be selected by chance.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Virtual Coach software | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Activity monitor and website | Intervention Type: OTHER; Name: Virtual Coach software; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Activity monitor and website; Assigned to Arm(s): Control
B: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: lifestyle counseling | Arm Label: Cognitive Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Training | Intervention Type: BEHAVIORAL; Name: lifestyle counseling; Assigned to Arm(s): Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Cognitive Training; Assigned to Arm(s): Cognitive Training
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Behavioral Weight Loss Program | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Stepped-Care Weight Loss Program | Intervention Type: BEHAVIORAL; Name: Standard Behavioral Weight Loss Program; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Stepped-Care Weight Loss Program; Assigned to Arm(s): 2
D: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Other: Lifestyle intervention, Behavioral: Physical activity, dietetic counselling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Other: Control | Intervention Type: OTHER; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Physical activity, dietetic counselling; Assigned to Arm(s): Lifestyle intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: "Mobile Stroke-Unit" for Reduction of the Response Time in Ischemic Stroke
Brief Summary: Stroke, the most common cause of permanent disability, the second most common cause of dementia and third most common cause of death, has tremendous socio-economic consequences.

Currently, systemic thrombolysis with the tissue plasminogen activator represents the only causal and approved treatment for acute ischemic stroke. However, the chances to save the brain tissue by a thrombolytic therapy exponentially decrease with proceeding time after onset of symptoms.

In most cases, the beginning of the thrombolysis therapy is delayed by a variety of factors, like delivery to the hospital, re-examinations and delay of blood analysis or of CT scans. Due to this, a thrombolytic therapy is possible only in a minority of the stroke patients (2-5 %). The aim of this study is to investigate whether a "Mobile Stroke Unit", a rescue car with an integrated CT scanner, necessary for essential diagnostics, contributes to a better stroke management by saving precious time until a therapeutic decision is made. The trial is planned as a monocentric, randomised prospective trial.


Options:
A: Arm Label: MSU; Type: EXPERIMENTAL; Interventions: Procedure: MSU | Arm Label: OCCM; Type: ACTIVE_COMPARATOR; Interventions: Procedure: OCCM | Intervention Type: PROCEDURE; Name: MSU; Assigned to Arm(s): MSU | Intervention Type: PROCEDURE; Name: OCCM; Assigned to Arm(s): OCCM
B: Arm Label: Telemedicine case management; Type: EXPERIMENTAL; Interventions: Device: Telemedicine Unit (HTU) | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: usual care | Intervention Type: DEVICE; Name: Telemedicine Unit (HTU); Assigned to Arm(s): Telemedicine case management | Intervention Type: OTHER; Name: usual care; Assigned to Arm(s): Usual care
C: Arm Label: Nurse administered; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse administered | Arm Label: Nurse & BP monitor; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse administered, Device: BP Monitor | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home BP Monitor; Type: EXPERIMENTAL; Interventions: Device: BP Monitor | Intervention Type: BEHAVIORAL; Name: Nurse administered; Assigned to Arm(s): Nurse & BP monitor, Nurse administered | Intervention Type: DEVICE; Name: BP Monitor; Assigned to Arm(s): Home BP Monitor, Nurse & BP monitor
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Remote patient monitoring (Partnership for the Heart) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Usual care group | Intervention Type: DEVICE; Name: Remote patient monitoring (Partnership for the Heart); Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Usual care group; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Automated Telephone Outreach With Speech Recognition to Improve Colorectal Cancer Screening: A Randomized Controlled Trial
Brief Summary: This large randomized controlled trial is testing the effectiveness of automated telephone outreach with speech recognition to improve rates of screening for colorectal cancer. The hypothesis is that the intervention improves rates of screening overall and specifically rates of colonoscopy.


Options:
A: Arm Label: Automated Telephone Outreach; Type: EXPERIMENTAL; Interventions: Behavioral: Automated Telephone Outreach with Speech Recognition | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Automated Telephone Outreach with Speech Recognition; Assigned to Arm(s): Automated Telephone Outreach
B: Intervention Type: BEHAVIORAL; Name: Disease Management Assessment; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early Intervention | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Delayed intervention | Intervention Type: BEHAVIORAL; Name: Early Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Delayed intervention; Assigned to Arm(s): 2
D: Arm Label: Automated Phone-Based Refill Reminders; Type: EXPERIMENTAL; Interventions: Behavioral: Automated Phone-Based Refill Reminders | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Automated Phone-Based Refill Reminders; Assigned to Arm(s): Automated Phone-Based Refill Reminders

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if an organized, consistent program of dietary and lifestyle counseling will prevent excessive gestational weight gain.


Options:
A: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention
B: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group
C: Arm Label: Children of obese women from a RCT; Type: N/A; Interventions: Behavioral: Lifestyle intervention during pregnancy | Arm Label: Children of obese mothers from a RCT, controls; Type: N/A; Interventions: N/A | Arm Label: Children born to normal weight women; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention during pregnancy; Assigned to Arm(s): Children of obese women from a RCT
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Therapeutic education | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Follow-up | Intervention Type: OTHER; Name: Therapeutic education; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Follow-up; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if an organized, consistent program of dietary and lifestyle counseling will prevent excessive gestational weight gain.


Options:
A: N/A
B: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Therapeutic education | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Follow-up | Intervention Type: OTHER; Name: Therapeutic education; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Follow-up; Assigned to Arm(s): 2
D: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle | Intervention Type: BEHAVIORAL; Name: Lifestyle; Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if an organized, consistent program of dietary and lifestyle counseling will prevent excessive gestational weight gain.


Options:
A: Arm Label: control; Type: NO_INTERVENTION; Interventions: Behavioral: motivational intervention in pregnancy | Intervention Type: BEHAVIORAL; Name: motivational intervention in pregnancy; Assigned to Arm(s): control
B: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group
C: Arm Label: Marinol; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Marinol D-40 | Arm Label: Nutrition counseling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Marinol D-40; Assigned to Arm(s): Marinol
D: Arm Label: Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Counseling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle Counseling; Assigned to Arm(s): Lifestyle Counseling

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if an organized, consistent program of dietary and lifestyle counseling will prevent excessive gestational weight gain.


Options:
A: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle | Intervention Type: BEHAVIORAL; Name: Lifestyle; Assigned to Arm(s): Intervention
B: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group
C: Arm Label: Lifestyle, follow-up, early care, standard care high/low risk; Type: OTHER; Interventions: Behavioral: Lifestyle: diet and exercise | Arm Label: Close follow-up; Type: OTHER; Interventions: Behavioral: Close follow-up: reporting diaries of food and exercise | Intervention Type: BEHAVIORAL; Name: Lifestyle: diet and exercise; Assigned to Arm(s): Lifestyle, follow-up, early care, standard care high/low risk | Intervention Type: BEHAVIORAL; Name: Close follow-up: reporting diaries of food and exercise; Assigned to Arm(s): Close follow-up
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Low glycemic load | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low fat diet | Intervention Type: BEHAVIORAL; Name: Low glycemic load; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low fat diet; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine if an organized, consistent program of dietary and lifestyle counseling will prevent excessive gestational weight gain.


Options:
A: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Other: Lifestyle intervention, Behavioral: Physical activity, dietetic counselling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: Other: Control | Intervention Type: OTHER; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Physical activity, dietetic counselling; Assigned to Arm(s): Lifestyle intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Low glycemic load | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low fat diet | Intervention Type: BEHAVIORAL; Name: Low glycemic load; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low fat diet; Assigned to Arm(s): 2
C: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group
D: Arm Label: Exercise training; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alcohol & HIV in Kenya: Stage 1 Trial of a Peer-Led Alcohol Behavior Intervention
Brief Summary: This study will determine whether a cognitive behavioral intervention that demonstrates strong evidence in the U.S. of reducing alcohol use is effective when delivered by paraprofessionals in Kenya and compared against a usual care support group.


Options:
A: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group
B: Arm Label: CBT; Type: EXPERIMENTAL; Interventions: Behavioral: CBT | Arm Label: HIV support group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HIV support group | Intervention Type: BEHAVIORAL; Name: HIV support group; Assigned to Arm(s): HIV support group | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): CBT
C: Arm Label: Intervention women with partners; Type: EXPERIMENTAL; Interventions: Behavioral: Protect your family | Arm Label: Intervention women without partners; Type: EXPERIMENTAL; Interventions: Behavioral: Protect your family | Arm Label: Control women with partners; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control women alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Protect your family; Assigned to Arm(s): Intervention women with partners, Intervention women without partners
D: Arm Label: Task-sharing approach to group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Task-sharing approach to group therapy | Arm Label: Enhanced standard of care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced standard of care | Intervention Type: BEHAVIORAL; Name: Task-sharing approach to group therapy; Assigned to Arm(s): Task-sharing approach to group therapy | Intervention Type: BEHAVIORAL; Name: Enhanced standard of care; Assigned to Arm(s): Enhanced standard of care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, 26-week Multicenter Randomized Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol (150 and 300 µg Once Daily [od]) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: This study evaluated the efficacy and safety of two doses of indacaterol in adults aged 40 or over with chronic obstructive pulmonary disease (COPD) in China and in two other countries.


Options:
A: Arm Label: Indacaterol 150 μg and tiotropium 18 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 μg, Drug: Tiotropium 18 μg | Arm Label: Tiotropium 18 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium 18 μg, Drug: Placebo to indacaterol | Intervention Type: DRUG; Name: Indacaterol 150 μg; Assigned to Arm(s): Indacaterol 150 μg and tiotropium 18 μg | Intervention Type: DRUG; Name: Tiotropium 18 μg; Assigned to Arm(s): Indacaterol 150 μg and tiotropium 18 μg, Tiotropium 18 μg | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Tiotropium 18 μg
B: Arm Label: indacaterol and glycopyrronium bromide (QVA149); Type: EXPERIMENTAL; Interventions: Drug: indacaterol and glycopyrronium bromide (QVA149) | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: tiotropium; Type: ACTIVE_COMPARATOR; Interventions: Drug: tiotropium | Intervention Type: DRUG; Name: indacaterol and glycopyrronium bromide (QVA149); Assigned to Arm(s): indacaterol and glycopyrronium bromide (QVA149) | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): tiotropium
C: Intervention Type: DRUG; Name: Budesonide/formoterol (SYMBICORT) pMDI; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Formoterol Turbuhaler; Assigned to Arm(s): N/A
D: Arm Label: Indacaterol 150 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 µg | Arm Label: Indacaterol 300 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 300 μg | Arm Label: Placebo to indacaterol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to indacaterol | Intervention Type: DRUG; Name: Indacaterol 150 µg; Assigned to Arm(s): Indacaterol 150 μg | Intervention Type: DRUG; Name: Indacaterol 300 μg; Assigned to Arm(s): Indacaterol 300 μg | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Placebo to indacaterol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Research to Programs for Trachoma Elimination: Antibiotic Trial
Brief Summary: Trachoma, an ocular infection caused by C. trachomatis, is the second leading infectious cause of blindness worldwide. Years of repeated infection with C. trachomatis cause the eyelid to scar and contract and ultimately to rotate inward such that the eyelashes rub against the eyeball and abrade the cornea (trichiasis). The World Health Organization (WHO) has endorsed a multi-faceted strategy to combat trachoma, which includes the use of antibiotic treatment to reduce the community pool of infection with C. trachomatis. The objective of this study is to conduct a randomized, community-based trial in three countries (Niger, Tanzania and The Gambia), representing different baseline endemicities, of alternative coverages and frequencies of administration of mass antibiotic treatment as well as to determine the cost-effectiveness of these different strategies from a program perspective.


Options:
A: Arm Label: J; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: K; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: L; Type: OTHER; Interventions: Drug: mass treatment with oral azithromycin | Arm Label: M; Type: OTHER; Interventions: Drug: mass treatment with oral azithromycin | Arm Label: N; Type: EXPERIMENTAL; Interventions: Drug: mass treatment with oral azithromycin | Arm Label: O; Type: EXPERIMENTAL; Interventions: Drug: mass treatment with oral azithromycin | Intervention Type: DRUG; Name: mass treatment with oral azithromycin; Assigned to Arm(s): L, M, N, O
B: Arm Label: ≥90% coverage with azithromycin target; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: 80%-89% coverage with azithromycin target; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: ≥90% coverage with azithromycin , treatment based; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: 80%-89% coverage with azithromycin : treatment based; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): 80%-89% coverage with azithromycin target, ≥90% coverage with azithromycin target | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): 80%-89% coverage with azithromycin : treatment based, ≥90% coverage with azithromycin , treatment based
C: Arm Label: Biannual mass oral azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Biannual mass oral placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Biannual mass oral azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Biannual mass oral placebo
D: Intervention Type: DRUG; Name: triple co administration at once of the combination of Albendazole + ivermectin + azithromycin; Assigned to Arm(s): N/A

Answer: B